Results 81 to 90 of about 5,422,838 (209)

Meningococcus, this famous unknown

Comptes Rendus Biologies, 2021
Neisseria meningitidis (meningococcus) is a Gram-negative bacterium responsible for two devastating forms of invasive diseases: purpura fulminans and meningitis.
dos Santos Souza, Isabel, Ziveri, Jason, Bouzinba-Segard, Haniaa, Morand, Philippe, Bourdoulous, Sandrine   +4 more
doaj   +1 more source

Invasive meningococcal disease and HIV coinfection

Communicable Diseases Intelligence, 2001
Three cases of meningococcal disease which occurred over a 3 year period in HIV-infected people living in the Wentworth Health Area of Sydney, Australia, are described. None of the 3 had ever received antiretroviral therapy which may have contributed to development of invasive meningococcal disease. Commun Dis Intell 2001;25:278-279.
openaire   +2 more sources

Greater Cochlear Damage in Otogenic Versus Meningogenic Meningitis: Hearing Rehabilitation Implications

The Laryngoscope, Volume 136, Issue 9, Page 3998-4005, September 2026.
Otogenic route of meningitis was associated with greater cochlear hair cell loss in comparison with the meningogenic one in this otopathology study. Neuronal depletion has been traditionally implicated in failed hearing rehabilitation of post‐meningitis deafness.
Matheus Pedrosa Tavares, Henrique Furlan Pauna, Rafael da Costa Monsanto, Nevra Keskin‐Yilmaz, Breno Lima de Almeida, Norma de Oliveira Penido   +5 more
wiley   +1 more source

How Do Climatic Factors Directly Influence the Incidence and Risk of Meningococcal Meningitis Across the African Meningitis Belt? A Narrative Literature Review

GeoHealth, Volume 10, Issue 9, September 2026.
Abstract Globally, the highest incidence of meningococcal meningitis occurs within the African meningitis belt, spanning 26 countries across sub‐Saharan Africa. Meningococcal meningitis incidence is highly seasonal in this region specifically, with outbreaks mostly occurring during the dry season, characterized by low rainfall and atmospheric humidity,
Molly Cliff, Kanny Diallo, Richard B. Yapi, Axelle B. D. Tano, Sally Jahn, Caroline M. Wainwright, Caroline Trotter   +6 more
wiley   +1 more source

Effectiveness of vaccinating household contacts in addition to chemoprophylaxis after a case of meningococcal disease: a systematic review. [PDF]

, 2008
SUMMARYWe performed a systematic review to estimate the effectiveness of vaccination, in addition to chemoprophylaxis, in preventing meningococcal disease among household contacts. Medline, EMBASE, EMGM, and EUIBIS were used for data collection.
Stuart, J.M., Hoek, M, Stefanoff, P., Christensen, H, Stefanoff, P, Stuart, JM, Howitz, M, Christensen, H., Hellenbrand, W., Hoek, MR, Hellenbrand, W, Hoek, M.R., Howitz, M.   +12 more
core   +1 more source

Engineered Bacterial Membranes as Next‐Generation Platforms for Cancer Immunotherapy

Small Science, Volume 6, Issue 8, August 2026.
Engineered bacterial membrane platforms, including outer membrane vesicles, bacterial ghosts, genetically engineered membranes, and hybrid bacterial–tumor membranes, integrate tumor antigen presentation with intrinsic immune stimulation. These platforms promote dendritic‐cell activation, T‐cell priming, pyroptosis, and synergistic responses with ...
Hafiza Aasia Malik, Urooj Yousaf Virk, Mohamed Salah Attia, Jenny Wilson, Ming Wei   +4 more
wiley   +1 more source

Prospective surveillance of invasive group a streptococcal disease, Fiji, 2005-2007. [PDF]

, 2009
We undertook a prospective active surveillance study of invasive group A streptococcal (GAS) disease in Fiji over a 23-month period, 2005-2007. We identified 64 cases of invasive GAS disease, which represents an average annualized all-ages incidence of 9.
Adam Jenney, E. Kim Mullholland, Batzloff, M, Steer, AC, Jonathan R. Carapetis, Kado, Joseph, Carapetis, JR, Good, Michael F, Carapetis, Jonathan R., Waqatakirewa, L, Jenney, A, Mullholland, E Kim, Jenney, Adam, Kado, J, Steer, Andrew C., Carapetis, Jonathan R, Andrew C. Steer, Good, Michael F., Lepani Waqatakirewa, Good, MF, Waqatakirewa, Lepani, Steer, Andrew C, Joseph Kado, Michael Batzloff, Michael F. Good, Mullholland, EK, Batzloff, Michael, Kim Mullholland, E.   +27 more
core   +1 more source

Meningocoxemic Septic Shock; A Case Report and Review of the Literature

Journal of Pediatric Emergency and Intensive Care Medicine, 2021
Meningococcal infections that have high mortality and morbidity in childhood and progress rapidly are an important health problem. It is one of the most important emergent diseases of the infectious diseases. Neisseria meningitidis has 13 serogroups.
Murat Özkale, Naime Gökay, Dinçer Yıldızdaş   +2 more
doaj   +1 more source

Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease [PDF]

Epidemiology and Infection, 2016
SUMMARYThe Global Meningococcal Initiative (GMI) is an international group of scientists and clinicians with recognized expertise in meningococcal disease including microbiology, immunology, epidemiology, public health and vaccinology. The GMI was established to promote the global prevention of meningococcal disease through education, research and ...
Vazquez, J. A., Taha, Muhamed-Kheir, Findlow, J., Gupta, S., Borrow, R.   +4 more
openaire   +4 more sources

Infection control in the brain and the eye

Acta Ophthalmologica, Volume 104, Issue 5, Page e478-e490, August 2026.
Abstract The Central Nervous System (CNS), comprising the brain and the eye, is considered to have a ‘privileged’ mechanism for dealing with immunological challenge (immune privilege, IP). CNS IP has been revealed through experiments using foreign protein antigens and cell and tissue alloantigens (grafts), but evidence for a role for IP in modulating ...
John V. Forrester, Paul G. McMenamin, Samantha J. Dando   +2 more
wiley   +1 more source